Research Study: ECLIPSE
Condition:
stable ischemic heart disease; unstable angina
Study Sponsor: Cardiovascular Systems
Study Investigator: Ivan Chavez, MD
Study Contact: JoAnne Goldman, RT
JoAnne.Goldman@allina.com
612-863-3793
Every research study comes with its own unique risks and benefits; the study team will assess whether you’re an eligible candidate and ensure you’re provided with all the information you need to decide if participating is right for you.
About this Study:

This trial will evaluate Orbital Atherectomy compared to conventional balloon angioplasty technique for the treatment of severely calcified lesions prior to implantation of drug-eluting stents (DES).
Eligibility Criteria:

  • Subject is 18 years of age or older.
  • Subject presents with:
    • stable ischemic heart disease or
    • acute coronary syndrome (NSTEMI or unstable angina), or
    • stabilized recent STEMI (>48 hours prior to randomization procedure)
  • Subject has signed the Institutional Review Board (IRB) or Ethics Committee (EC) approved ECLIPSE trial Informed Consent Form (ICF) prior to any trial related procedures.

Interested in participating in this study?

Reach out to the study contact directly, or fill out this form and we will contact you and assess whether you are an eligible candidate!